Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TNFRSF13C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FHDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PNMA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR93 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASZ1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PATJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ITPKB-IT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADAM12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00643 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2C19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDGA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6883 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPTAN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on